Alpha Teknova is a producer of critical reagents—including pre-poured media plates, liquid microbial culture media, and molecular biology reagents—that support the discovery, development, and commercial manufacturing of therapies, vaccines, and diagnostics. The company serves over 3,000 customers in the life sciences market, ranging from pharmaceutical and biotechnology companies to contract manufacturers, diagnostics franchises, and academic institutions, through a tiered revenue model in which customers typically begin with catalog products during research, transition to custom formulations during development, and advance to regulated GMP-grade products for commercial production. Teknova generates revenue from two segments: Lab Essentials, comprising research-use-only catalog and custom products, and Clinical Solutions, comprising certified manufacturing-grade custom products; the company differentiates itself through rapid custom formulation capabilities, deep customer validation relationships that create switching costs, and ISO 13485 quality systems that enable customers to scale from research to regulated commercial manufacturing.